Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
IL-13 receptor α 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis
2003
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
2004
Tissue expression of PD-L1 mediates peripheral T cell tolerance
2006
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow
2013
Antigen‐specific production of interleukin (IL)‐13 and IL‐5 cooperate to mediate IL‐4Rα‐independent airway hyperreactivity
2003
Type 2 cytokines: mechanisms and therapeutic strategies
2015
Inflammation in Chronic Venous Insufficiency: Is the Problem Insurmountable?
1999
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Cellular and molecular mechanisms of fibrosis
2007 Standout
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
2003
Host tissue determinants of tumour immunity
2019
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma
2007
Animal models of chronic obstructive pulmonary disease
2008
miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity
2017
Evaluation of the Role of Intercellular Adhesion Molecule 1 in a Rodent Model of Chronic Venous Hypertension
2000
Antitumour actions of interferons: implications for cancer therapy
2016
Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium
2005
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
The VCAM-1 Gene That Encodes the Vascular Cell Adhesion Molecule Is a Target of the Sry-related High Mobility Group Box Gene, Sox18
2004
The diverse functions of the PD1 inhibitory pathway
2017
Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis
2003
P-selectin suppresses hepatic inflammation and fibrosis in mice by regulating interferon γ and the IL-13 decoy receptor
2004
Selectins Influence Thrombosis in a Mouse Model of Experimental Deep Venous Thrombosis
2002
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis
2004
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
2004
Capillary pericytes regulate cerebral blood flow in health and disease
2014 StandoutNature
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
P-selectin and leukocyte microparticles are associated with venous thrombogenesis
2003
Hibernation confers resistance to intestinal ischemia-reperfusion injury
2006
PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells
2004
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Cancer immunotherapy comes of age
2011 StandoutNature
IL-12 Regulates B7-H1 Expression in Ovarian Cancer-associated Macrophages by Effects on NF-κB Signalling
2014
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells
2004 StandoutNobel
Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice
2007
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Vascular bed-specific thrombosis
2007
Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury
2009
Microglial Expression of the B7 Family Member B7 Homolog 1 Confers Strong Immune Inhibition: Implications for Immune Responses and Autoimmunity in the CNS
2005
The B7–CD28 superfamily
2002
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
2007
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Pathophysiology of ischaemia-reperfusion injury
2000 Standout
Ischemia‐Reperfusion: Mechanisms of Microvascular Dysfunction and the Influence of Risk Factors for Cardiovascular Disease
1999
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
2003 StandoutNobel
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Phenotypic Heterogeneity of the Endothelium
2007
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune Response
2003
CD8+ T Cell Effector Mechanisms in Resistance to Infection
2000
B7x: A widely expressed B7 family member that inhibits T cell activation
2003 StandoutNobel
Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo
2005
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.
2003
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis
2000
Phenotypic Heterogeneity of the Endothelium
2007
Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8 + T-Cell–Mediated Injury in the Heart
2007
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Disease Tolerance as a Defense Strategy
2012 StandoutScience
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
The phenotype of murine wound macrophages
2009
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo
2005
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
2004
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability
2007 StandoutNobel
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
2003
Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis
2003
Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production
2003
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis
2002
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation
2000
Works of Michael J. Eppihimer being referenced
Lung Neutrophil Retention and Injury After Intestinal Ischemia/Reperfusion
1997
ISCHEMIA/REPERFUSION-INDUCED LEUKOCYTE-ENDOTHELIAL INTERACTIONS IN POSTCAPILLARY VENULES
1997
Effects of Leukocyte-Capillary Plugging on the Resistance to Flow in the Microvasculature of Cremaster Muscle for Normal and Activated Leukocytes
1996
[2] In vivo measurements of endothelial cell adhesion molecule expression
1999
Human bronchial epithelial cells express and secrete MMP-12
2004
Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia
2005
Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells
2002
Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse.
1997
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.
2002
Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells
2002
P-Selectin–Dependent Inhibition of Thrombosis During Venous Stasis
2000
Complement-mediated lung injury and neutrophil retention after intestinal ischemia-reperfusion
1997
Modulation of P-selectin expression in the postischemic intestinal microvasculature
1997
Heterogeneity of Expression of E- and P-Selectins In Vivo
1996
Endothelial cell adhesion molecule expression in gene-targeted mice
1997
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
2003